Vanguard Capital Management’s Citius Oncology CTOR Stock Holding History
Bought
Maintained
Sold
Other funds holding CTOR
PSWL
Vanguard Capital Management's CTOR Position: Q3 2026 in Review
Vanguard Capital Management held its Citius Oncology (CTOR) position steady in Q3 2026 at 546,325 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.
Vanguard Capital Management first reported a position in CTOR in Q1 2026 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.
- Vanguard Capital Management held 546,325 shares of Citius Oncology worth $552K as of Q3 2026.
- Vanguard Capital Management left its Citius Oncology share count unchanged in Q3 2026.
- Citius Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3671 holding.
- Vanguard Capital Management first reported a position in Citius Oncology in Q1 2026 and has held it in 3 quarters since.
- 22 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.